4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-16-114217
$TCRTCIK 0001107421operating
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:33 PM ET
Size
8.5 KB
Accession
0001209191-16-114217
Insider Transaction Report
Form 4
Fowler Wyche
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2016-04-04−15,000→ 0 totalExercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying) - Tax Payment
Common Stock
2016-04-04$7.92/sh−11,694$92,616→ 134,310 total - Exercise/Conversion
Common Stock
2016-04-04$5.01/sh+15,000$75,150→ 146,004 total
Footnotes (1)
- [F1]Represents shares withheld to pay the exercise price and withholding tax obligations.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:33 PM ET
- Size
- 8.5 KB